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Susceptibility to ATP depletion of primary
proximal tubular cell cultures derived from mice
lacking either the α1 or the α2 isoform of the
catalytic domain of AMPK
Wilfred Lieberthal1,2*, Meiyi Tang1,2, Leiqing Zhang1,2, Benoit Viollet3,4,5, Vimal Patel6,7 and Jerrold S Levine6,7
Abstract
Background: The purpose of this study was to determine whether AMPK influences the survival of primary cultures
of mouse proximal tubular (MPT) cells subjected to metabolic stress. Previous studies, using an immortalized MPT
cell line, suggest that AMPK is activated during metabolic stress, and ameliorates stress-induced apoptosis of these
cells.
Methods: Primary MPT cells were cultured from AMPK knockout (KO) mice lacking either the α1 or the α2 isoform
of the catalytic domain of AMPK. MPT cells were subjected to ATP depletion using antimycin A.
Results: Surprisingly, there was no difference in the amount of death induced by metabolic stress of MPT cells
from either type of AMPK KO mice compared to its WT control. Moreover, inhibition of the activity of the α1
isoform in primary MPT cells from α2−/− mice (pharmacologically, via compound C) or inhibition of the α2 isoform
in primary MPT cells from α1−/− mice (molecularly, via knockdown) both decreased cell viability equivalently in
response to metabolic stress. The explanation for this unexpected result appears to be an adaptive increase in
expression of the non-deleted α-isoform. As a consequence, total α-domain expression (i.e. α1 + α2), is comparable
in kidney cortex and in cultured MPT cells derived from either type of KO mouse versus its WT control. Importantly,
each α-isoform appears able to compensate fully for the absence of the other, with respect to both the
phosphorylation of downstream targets of AMPK and the amelioration of stress-induced cell death.
Conclusions: These findings not only confirm the importance of AMPK as a pro-survival kinase in MPT cells during
metabolic stress, but also show, for the first time, that each of the two α-isoforms can substitute for the other in
MPT cells from AMPK KO mice with regard to amelioration of stress-induced loss of cell viability.
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Background
AMP-activated protein kinase (AMPK) is a ubiquitously
expressed and highly conserved serine/threonine kinase
that is activated by any form of stress that reduces cell
energy stores [1,2]. AMPK is a heterotrimeric protein
composed of a catalytic α subunit and two regulatory (β
and γ) subunits [1]. There are two isoforms of the
catalytic (α1 and α2) and β (β1 and β2) subunits, and
three isoforms of the γ (γ1, γ2, and γ3) subunit, all of
which are encoded by different genes [1]. AMPK is acti-
vated by phosphorylation of a threonine residue (Thr172)
situated within the activation loop of the α-subunit
[3-5]. The best-defined upstream AMPK kinase is liver
kinase B1 (LKB1). LKB1 is constitutively active, so that
AMPK is continuously being phosphorylated [3-5].
When cell energy stores are replete, AMPK is main-
tained in an inactive state by the activity of phosphatases
such as phosphatase-2C alpha [1,3,4]. Activation of
AMPK occurs whenever cell stress leads to a decrease in
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cytosolic ATP levels and a concomitant increase in levels
of adenosine diphosphate (ADP) and adenosine mono-
phosphate (AMP) [3,4]. The regulatory γ-subunit of
AMPK has binding sites for all three nucleotides [6,7].
Binding of ADP or AMP to the γ-subunit activates
AMPK via two mechanisms, inhibition of the dephos-
phorylation of Thr172 and allosteric facilitation of phos-
phorylation of AMPK by LKB1 [3,4]. In contrast to the
effects of ADP and AMP, binding of ATP to the γ sub-
unit of AMPK promotes its deactivation [1,3,4]. The net
result of these opposing interactions is that AMPK activ-
ity is inversely related to the ratio of the concentration
of ATP to that of ADP and AMP [3,4,7].
Upon activation, AMPK phosphorylates and alters the
activity of multiple downstream kinases and enzymes
[8,9]. AMPK also induces changes in gene expression
[10]. Together, these effects of AMPK lead to alterations
in glucose, protein, and lipid metabolism that serve to
conserve energy stores by promoting ATP production,
inhibiting ATP consumption, and facilitating the cellular
uptake of nutrients [1,2,8,9,11,12]. For example, through
phosphorylation and inhibition of acetyl-CoA carboxylase
1 (ACC1) and ACC2, AMPK inhibits lipid synthesis and
promotes fatty acid oxidation [1,13-15]. By inhibiting the
activity of the mammalian target of rapamycin (mTOR),
AMPK also inhibits protein synthesis [16,17]. Other
AMPK-mediated effects include increased cellular uptake
of glucose and fatty acids, and increased glycolysis [9].
Recently, using an immortalized mouse proximal tubu-
lar (MPT) cell line, we have shown that AMPK is acti-
vated by ATP depletion, and that, once activated, AMPK
ameliorates apoptosis induced by this form of stress
[18]. Here we extend these findings to primary cultures
of MPT cells, derived from the kidneys of AMPK knock-
out (KO) mice with whole body deletions of either the
α1 (α1−/−) or the α2 (α2−/−) isoforms of AMPK. We hy-
pothesized that primary MPT cells, lacking one or other
of the α-isoforms of AMPK, should be more susceptible
to apoptosis induced by ATP depletion than primary
MPT cells with both α-isoforms intact. Surprisingly, we
found no difference in the severity of antimycin-induced
cell death in MPT cells from α1−/− or α2−/− mice versus
their WT controls. Moreover, we found that a reduction
of AMPK activity (via either pharmacologic inhibition or
knockdown of one of the α-isoforms) led to comparable
increases of antimycin-induced apoptosis in primary
MPT cells from KO versus WT mice.
In explaining this absence of a difference in stress-
induced apoptosis for MPT cells from KO versus WT
mice, we show that there is a compensatory up-regulation
in expression of the intact α-isoform in both AMPK KO
mice. This up-regulation compensates fully for the deleted
α-isoform, such that the total amount of α-domain protein
is comparable in primary MPT cells from the two KO mice
versus their WT controls. These findings not only confirm
the importance of AMPK activation as a pro-survival kin-
ase during ATP depletion, but also indicate that each of
the two α-isoforms can substitute for the other in amelior-
ating the consequences of metabolic stress.
Methods
Materials
All chemicals were purchased from Sigma (MO) unless
otherwise stated. Soybean trypsin inhibitor was purchased
from GIBCO (NY). Rabbit polyclonal antibody to total
AMPK, rabbit polyclonal antibody to total alpha subunit
of AMPK, and mouse monoclonal antibody to the phos-
phorylated alpha subunit of AMPK were purchased from
Cell Signaling Technologies (MA). Rabbit polyclonal anti-
body to phosphorylated ACC1/2 was purchased from Up-
state (NY). Rabbit polyclonal antibodies specific for the α1
and α2 isoforms of the catalytic domain of AMPK were
purchased from Abcam (MA). Monoclonal antibody to β-
actin was purchased from Chemicon (CA).
Mice
The generation and phenotype of whole body α1−/− and
α2−/− KO mice have been described previously [19,20].
α1−/− mice and their WT controls were bred on a mixed
background (C57BL6J/129Sv), whereas α2−/− KO mice
and their WT controls were bred on a C57BL6J back-
ground. Heterozygous α1−/− and –α2−/− KO mice, used
only for breeding, were obtained from the European
Mouse Mutant Archive and bred in the Department for
Laboratory and Animal Research at Stony Brook Hos-
pital. Only homozygous KO mice, male and female, were
used for experimentation. All studies were approved by
the IACUC at Stony Brook Hospital. Total body weights
and kidney weights were comparable amongst KO and
WT mice (data not shown).
Primary culture of mouse proximal tubular (MPT) cells
Techniques for the primary culture of MPT cells are well
established in our laboratory [21,22]. Briefly, kidneys were
harvested from mice at 4–6 weeks of age. Cortical tissue
was finely minced and incubated in Hanks’s solution con-
taining collagenase and soybean trypsin inhibitor. After
collagenase digestion, 10% horse serum was added, and
the tissue fragments were gently centrifuged. After two
washes with DMEM, tissue fragments were suspended in
growth medium, a serum-free, defined medium consisting
of DMEM/Ham’s F-12 media (1:1) containing 2 mM glu-
tamine, 15 mM HEPES (pH 7.2), 5 μg/ml transferrin,
5 μg/ml insulin, 50 mM hydrocortisone, 500 U/ml penicil-
lin, and 50 mg/ml streptomycin. The tissue fragments,
suspended in growth medium, were then plated on plastic
tissue cultures plates and incubated in a humidified
air/CO2 incubator (5% v/v) at 37°C.
Lieberthal et al. BMC Nephrology 2013, 14:251 Page 2 of 13
http://www.biomedcentral.com/1471-2369/14/251
Fragments of tubules adhere to the culture dish, and
MPT cells grow out of the tubules to form confluent
monolayers over a 4–5 day period. MPT cells express
megalin and other markers specific for proximal tubular
cells. Five days after plating, the medium was changed to
experimental medium, which consists of DMEM/Hams
F12 containing HEPES (pH 7.2), 15 mM glutamine, 500
U/ml penicillin, and 50 mg/ml streptomycin. No insulin,
hydrocortisone, or transferrin was added to this medium.
Experiments were begun on the sixth day after plating.
Metabolic stress (graded ATP depletion)
MPT cells were exposed to metabolic stress using anti-
mycin A, a mitochondrial inhibitor. We examined the
effect of antimycin A in the presence of three concentra-
tions of dextrose, 10, 5, and 2.5 mM. The severity of
metabolic stress increases progressively, (i.e. cell ATP
levels fall progressively), as the dextrose concentration in
the medium is reduced from 10 to 2.5 mM. We refer to
this model of metabolic stress as “graded” ATP deple-
tion. We have used graded ATP depletion as a model of
metabolic stress in previous publications [22]. Control
(unstressed) MPT cells were incubated in 5 mM dex-
trose in the absence of antimycin.
Cell ATP levels
ATP levels were determined using previously described
methods [22]. Briefly, cell ATP content was measured by
luciferase assay in cell lysates and normalized to total
cellular protein, as assessed by bicinchoninic acid (BCA)
protein assay (Pierce, Rockford, NY). Control ATP levels,
obtained in cells incubated in dextrose-containing medium
(5 mM) in the absence of antimycin, were expressed as
nanomoles of ATP per milligram of cell protein (nM
ATP/mg protein). ATP levels obtained during metabolic
stress were expressed as a percentage of ATP levels under
control conditions.
Immunoblotting
Immunoblotting was performed as previously described
[23]. Briefly, cells were washed with ice-cold PBS, then
lysed in ice-cold cell lysis buffer (20 mM Tris–HCl,
pH 7.5, containing 130 mM NaCl, 1% v/v Triton X-100,
0.5% w/v deoxycholate, 0.1% w/v SDS, 1 mM DTT,
10 mM sodium pyrophosphate, 5 mM sodium fluoride,
1 mM phenylmethylsulfonyl fluoride, and 200 μM so-
dium orthovanadate). Lysates were centrifuged at 10,000 × g
for 10 min at 4°C, and the supernatants were stored
at −70°C. Protein samples, 20 μg per lane, as determined
by BCA protein assay, were boiled in 6× reducing sam-
ple buffer, electrophoresed on SDS-polyacrylamide gels,
and transferred to nitrocellulose membranes (BIO-RAD,
Hercules, CA). Membranes were blocked with either 2.5%
bovine serum albumin or 5% dry milk in TBS, before
probing with primary antibody. After incubation with the
appropriate secondary antibody, immunoreactive bands
were visualized by the Western Lightning Chemilumines-
cence Reagent Plus (PerkinElmer, Boston, MA).
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Figure 1 Effect of metabolic stress on the viability of MPT cells from α1−/− and α2−/− KO mice. A: MPT cells from α1−/− mice (upper panel)
or α2−/− KO mice (lower panel), or their WT controls, were subjected to graded metabolic stress by incubation in the presence of antimycin
(2 μM) and varying concentrations of dextrose. After 16–18 hrs, the percentage of viable cells remaining was determined by flow cytometry
(n = 5 for both experiments). * p < 0.02, 5 mM dextrose vs. 10 mM dextrose; # p < 0.02, 2.5 mM dextrose vs. 5 mM dextrose. B: Representative flow
cytometric analysis of MPT cells from α1−/− mice (right panels) and their WT control (left panels) incubated in antimycin (2 μM) plus varying
concentrations of dextrose. Cell viability was quantified by staining cells with calcein AM (x-axis) and ethidium homodimer-1 (Eth-H1) (y-axis). For
each condition, 10,000 cells were analyzed, and the percentage of viable cells was calculated by dividing the number of calcein-positive and
Eth-H1-negative cells by the total number of cells counted.
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Figure 2 Effect of metabolic stress on cytosolic ATP levels in MPT cells from α1−/− and α2−/− KO mice. MPT cells from α1−/− mice or
α2−/− KO mice, or their WT controls, were subjected to graded ATP depletion by incubation in the presence of antimycin (2 μM) and varying
concentrations of dextrose for 4 hrs. Cell ATP levels were measured and normalized to cell protein content. All values are expressed as a percent
of ATP levels in MPT cells incubated under control conditions (10 mM dextrose, in the absence of antimycin). * p < 0.02, antimycin plus 10 mM
dextrose vs. control conditions; # p < 0.01, antimycin plus 5 mM dextrose vs. antimycin plus 10 mM dextrose; p < 0.01, antimycin plus 2.5 mM
dextrose vs. antimycin plus 5 mM dextrose.
Figure 3 Relative expression of the catalytic alpha (α) domain of AMPK in whole kidney cortex obtained from α1−/− and α2−/−
knockout (KO). The relative expression of the α1 and α2 isoforms of AMPK, and of the total α(α1 + α2) domain, was evaluated in immunoblots
of lysates of “snap frozen” samples of kidney cortex, obtained from α1−/− or α2−/− KO mice and their WT controls. Upper panel: Representative
immunoblot. Molecular weight markers (in kDa) are shown on the right of each immunoblot. Lower panel: Densitometric quantitation of three
immunoblots using β-actin as a loading control. * p < 0.01, α1−/− vs. WT mice, for α2 isoform expression; # p < 0.02, α2−/− vs. WT mice, for α1
isoform expression.
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Cell viability
Cell viability was determined using the LIVE/DEAD
Assay Kit purchased from Molecular Probes™ and used
according to the manufacturer’s instructions. In brief,
MPT cells were stained with ethidium homodimer-1
(EthD-1) and calcein AM. Live cells are identified by
their ability to convert calcein AM, a non-fluorescent
cell-permeant agent to calcein, an intensely fluorescent
dye (excitation/emission wavelengths, ~495 nm/~515 nm)
that is retained within live cells. Dead cells are identified
by nuclear staining for EthD-1, which only enters cells
with damaged plasma membranes and, upon binding
to nucleic acids, undergoes a 40-fold enhancement of
fluorescence (excitation/emission wavelengths, ~495 nm/
~635 nm), thereby producing a bright fluorescence in
dead cells. Since both dyes are essentially non-fluorescent
before interacting with cells, background fluorescence is
inherently low. Live and dead cells were quantitated using
flow cytometry (FACScan, BD Biosciences), and data
were analyzed using CELLQuestPro Version 3.3 (BD
Biosciences). Cells were first analyzed by forward versus
side scatter, and gated to remove debris, cell fragments,
and cell aggregates. The proportion of live cells in each
sample was expressed as a percent of the total number of
cells analyzed (10,000/sample).
Statistics
All data are presented as mean ± standard error (SE). Stu-
dent’s t-test was used for comparing cell ATP levels and
densitometry of immunoblots. The Bonferroni correction
was applied when multiple comparisons were made. The
viability of MPT cells cultured from KO versus WT mice
and subjected to metabolic stress was compared by
ANOVA for repeated measures using STATA® Data Ana-
lysis and Statistical Software. All p values <0.05 were con-
sidered statistically significant.
Results
Effect of metabolic stress on the viability of MPT cells
from α1−/− and α2−/− versus WT mice
We determined the effect of graded ATP depletion, in-
duced by exposing MPT cells to antimycin A and varying
concentrations of dextrose, on cell viability, as assessed by
flow cytometry. Cell viability was comparable in MPT cells
from KO versus WT mice under unstressed control con-
ditions (10 mM dextrose, no antimycin) (data not shown).
Figure 4 Relative expression of the catalytic alpha (α) domain of AMPK in proximal tubular cells derived from α1−/− and α2−/−
knockout (KO) mice. The relative expression of the α1 and α2 isoforms of AMPK, as well as of the total α domain (α1 + α2), was evaluated in
immunoblots of lysates from confluent mouse proximal tubular (MPT) cells derived from the kidneys of either α1−/− or α2−/− KO mice, or their WT
controls. Upper panel: Representative immunoblot. Molecular weight markers (in kDa) are shown on the right of each immunoblot. Lower panel:
Densitometric quantitation of three immunoblots using β-actin as a loading control. * p < 0.02, α1−/− vs. WT mice, for α2 isoform expression;
# p < 0.02, α2−/− vs. WT mice, for α1 isoform expression.
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In the presence of antimycin, the percentage of viable
MPT cells from AMPK KO and WT mice decreased pro-
gressively as the concentration of dextrose was decreased
(Figure 1). Nevertheless, at each dextrose concentration,
the survival of MPT cells from α1−/− or α2−/− KO mice
was no different than that of MPT cells from WT controls
(Figure 1).
Effect of metabolic stress on cytosolic ATP levels in MPT
cells from α1−/− and α2−/− mice
Cytosolic ATP levels in control unstressed MPT cells in-
cubated in 10 mM dextrose without antimycin for 4 hrs
were no different for KO versus WT controls (21 ±8
nM/mg protein versus 23 ± 6 nM/mg protein for α1−/−
mice; and 26 ± 9 nM/mg protein versus 21 ± 7 nM/mg
protein for α2−/− mice). Incubation of MPT cells in the
presence of antimycin for 4 hrs led to a reduction in
ATP levels. The severity of ATP depletion was inversely
proportional to the concentration of dextrose in the
medium (Figure 2). However, the severity of ATP
depletion did not differ in MPT cells from KO versus
WT mice at any dextrose concentration (Figure 2).
Relative expression of the catalytic alpha domains of AMPK
in whole kidney cortex and in cultured proximal tubular
cells obtained from α1−/− and α2−/− KO and WT mice
We used immunoblotting to determine the relative ex-
pression of the α1 and α2 isoforms of AMPK, as well as
total α domain expression (α1 + α2 isoforms), in lysates
obtained from whole kidney cortex (Figure 3) and con-
fluent monolayers of MPT cells (Figure 4), both derived
from AMPK KO mice and their WT controls. As ex-
pected, we detected no expression of the deleted α1 or
α2 isoform in lysates from either whole kidney cortex
(Figure 3) or MPT cell cultures (Figure 4) obtained from
the α1−/− and α2−/− mice, respectively. Notably, however,
expression of the non-deleted α-isoform was markedly
increased in kidney cortex and MPT cell cultures from
AMPK KO mice when compared to their WT controls
(Figures 3 and 4). As a result, total alpha domain
Figure 5 Effect of metabolic stress on activation of the AMPK pathway in MPT cells from α1−/− and α2−/− KO mice. MPT cells obtained
from α1−/− or α2−/− KO mice, or their WT controls, were subjected to metabolic stress by incubation in medium containing dextrose (5 mM) plus
antimycin (2 μM) for 4 hrs. Control cells were incubated in dextrose in the absence of antimycin. Activation of the AMPK pathway was assessed
by immunoblotting using antibodies that recognize either the phosphorylated (activated) form of AMPK or the phosphorylated (inhibited) form
of acetyl coenzyme A carboxylase (ACC). Expression of total AMPK was also assessed. Upper panel: Representative immunoblot. Molecular weight
markers (in kDa) are shown on the right of each immunoblot. Lower panel: Densitometric quantitation of three immunoblots using β-actin as a
loading control. * p < 0.001, presence vs. absence of antimycin in MPT cells from α1−/− mice, α2−/−KO mice and their WT controls.
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expression was comparable in kidney cortex and MPT
cell cultures for both types of AMPK KO mouse versus
its WT controls (Figures 3 and 4).
Effect of metabolic stress on activation of the AMPK
pathway in MPT cells from α1−/− and α2−/− mice
We next compared the degree to which AMPK is activated
by metabolic stress in MPT cells from AMPK KO versus
WT mice. Metabolic stress was induced by treatment of
cells with antimycin in the presence of 5 mM dextrose. Ac-
tivation of AMPK was assessed by immunoblotting for
phosphorylation of Thr172 within the catalytic α domain of
AMPK. Upon activation, AMPK phosphorylates a number
of downstream targets [1,3-5]. As a further measure of
AMPK activation, we evaluated the extent of phosphoryl-
ation of ACC at Ser79, an event that inhibits ACC activity.
We chose ACC, since it is one of the more thoroughly
studied downstream targets of AMPK [1].
Treatment with antimycin increased phosphorylation
of both AMPK and ACC to a comparable extent in
MPT cells from α1−/− and α2−/− mice versus their WT
controls (Figure 5). These data suggest that the identity
of the alpha domain isoform does not influence the de-
gree to which AMPK is activated by antimycin-induced
metabolic stress, and that each isoform can substitute
for the absence of the other.
Effect of pharmacologic inhibition of AMPK on stress-induced
activation of AMPK in MPT cells from AMPK KO and WT mice
We examined the effect of compound C (CC), a pharma-
cologic inhibitor of AMPK, on AMPK activity during
metabolic stress in MPT cells from α2−/− and WT mice.
Antimycin increased the phosphorylation of both AMPK
and its downstream target, ACC, in MPT cells from α2−/−
and WT mice (Figure 6). CC comparably reduced the
stress-induced increase in phosphorylation of AMPK and
ACC in MPT cells from α2−/− versus WT mice (Figure 6).
Similar results, in the absence and presence of CC, were
obtained in MPT cells from α1−/− versus WT mice (data
not shown).
Figure 6 Effect of pharmacologic inhibition of AMPK using compound C (CC) on the activity of the AMPK pathway in MPT cells from
α2−/− KO and WT mice. MPT cells from α2−/− mice, or their WT control, were subjected to ATP depletion by incubation in medium containing
dextrose (5 mM) and antimycin (2 μM), in the presence or absence of CC (20 μM) for 4 hrs. Activation of the AMPK pathway was assessed by
immunoblotting, using antibodies that recognize either the phosphorylated (activated) form of AMPK, or the phosphorylated (inhibited) form of
ACC. Expression of total alpha domain was also assessed. Upper panel: Representative immunoblot. Molecular weight markers (in kDa) are shown
on the right of each immunoblot. Lower panel: Densitometric quantitation of three immunoblots using β-actin as a loading control. * p < 0.01,
presence vs. absence of CC, for MPT cells from WT mice treated with antimycin; # p < 0.01, presence vs. absence of CC, for MPT cells from
α2−/− mice treated with antimycin.
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Effect of pharmacologic inhibition of AMPK on viability of
metabolically stressed MPT cells from AMPK KO and WT mice
We next examined the effect of CC on MPT cell viability
during metabolic stress. MPT cells from α2−/− mice and
their WT controls were subjected to graded ATP deple-
tion (antimycin in the presence of varying concentra-
tions of dextrose) for 16–18 hrs, in the presence of
either CC (20 μM) or its vehicle. Control cells were
incubated in dextrose without antimycin. In the absence
of CC, metabolic stress induced a comparable decrease
of viability in MPT cells from α2−/− versus WT mice
(Figure 7). Although inhibition of AMPK with CC re-
duced MPT cell viability at all degrees of metabolic
stress, the reduction in viability induced by CC was
comparable in MPT cells from α2−/− versus WT mice
(Figure 7). Furthermore, regardless of the presence or
absence of CC, ATP levels in metabolically stressed
MPT cells did not differ for α2−/− versus WT mice (data
not shown). These data are consistent with those of im-
munoblotting (Figures 5 and 6).
We performed similar experiments using MPT cells
from α1−/− versus WT mice. In the absence of CC,
metabolic stress (antimycin plus 5 mM dextrose) re-
duced cell viability to a similar extent in MPT cells from
α1−/− versus WT mice (64 ± 7% and 59 ± 8% of control,
respectively). CC comparably exacerbated the stress-
induced loss of cell viability in MPT cells from α1−/− ver-
sus WT mice (35 ± 6% and 38 ± 7% of control,
respectively). Thus, the effects of CC on the viability of
stressed MPT cells was similar for α1−/− and α2−/− mice,
as compared to their WT controls.
Effect of knockdown of the α2 isoform on expression and
activation of the AMPK pathway in α1−/− and WT mice
MPT cells from α1−/− or WT mice were infected with ei-
ther control (scrambled) shRNA or shRNA designed to
knock down expression of the α2 isoform of AMPK. In-
fection with control shRNA did not alter expression of
either the α2 isoform of AMPK or total α-domain
AMPK in MPT cells from α1−/− and WT mice (Figure 8).
In contrast, infection with anti-α2 shRNA significantly
reduced expression of the α2 isoform of AMPK as well
as total alpha domain AMPK in MPT cells from both
α1−/− and WT mice (Figure 8).
We next determined the effect of knockdown of the
α2 isoform of AMPK on metabolic stress-induced acti-
vation of the AMPK pathway. MPT cell monolayers
from α1−/− and WT mice were infected with either con-
trol or anti-α2 shRNA. Following infection, MPT cells
were incubated in dextrose (5 mM) in the absence or
presence of antimycin. In cells infected with control
shRNA, metabolic stress induced marked phosphoryl-
ation of both AMPK and ACC (Figure 9). Infection with
anti-α2 shRNA led to a marked but comparable reduc-
tion in phosphorylation of AMPK and ACC in MPT cells
from α1−/− versus WT mice (Figure 9).
Figure 7 Effect of pharmacologic inhibition of AMPK on viability of MPT cells from α2−/− KO and WT mice subjected to metabolic
stress. A: MPT cells from α2−/− mice, or their WT control, were subjected to graded ATP depletion by incubation in the presence of antimycin
(2 μM) and varying concentrations of dextrose for 16–18 hrs, in either the absence (solid lines) or the presence (dashed lines) of CC (20 μM). The
percentage of viable cells remaining was determined by flow cytometry (n = 5). * p < 0.01, absence vs. presence of CC, for MPT cells from either
α2−/− mice or their WT control (ANOVA for repeated measures). B: Representative flow cytometric analysis of metabolically stressed MPT cells
from α2−/− mice incubated in the absence (left panels) or presence (right panels) of CC (20 μM). Cell viability was quantified by staining cells with
calcein AM (x-axis) and ethidium homodimer-1 (Eth-H1) (y-axis). For each condition, 10,000 cells were analyzed, and the percentage of viable cells
was calculated by dividing the number of calcein-positive and Eth-H1-negative cells by the total number of cells counted.
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Effect of knockdown of the α2 isoform of AMPK on viability
of metabolically stressed MPT cells from α1−/− KO mice
Finally, we examined the effect of knockdown of the α2
isoform of AMPK on the viability of metabolically
stressed MPT cells. MPT cells from α1−/− and WT mice
were infected with either control shRNA or anti-α2
shRNA, and then incubated in the absence or presence
of antimycin plus varying concentrations of dextrose.
After 16–18 hrs, the percentage of viable cells was deter-
mined by flow cytometry. As with pharmacologic inhib-
ition of AMPK by CC, knockdown of the α2 domain
comparably decreased the viability of metabolically
stressed MPTcells from α1−/− versus WTmice (Figure 10).
Regardless whether cells were infected with control or
anti-α2 shRNA, ATP levels did not differ in metabolically
stressed MPT cells from α1−/− versus WT mice (data not
shown). Taken together, our studies on the effects of
AMPK inhibition, accomplished either pharmacologically
or molecularly, demonstrate antimycin-induced metabolic
stress comparably activates the α1 and α2 isoforms of
AMPK, and that either isoform can substitute for the
other in ameliorating stress-induced cell death.
Discussion
Increased activity of AMPK contributes to the pathogen-
esis of a wide range of diseases, including diabetes melli-
tus, the metabolic syndrome, neurodegenerative disorders,
and cancer [24-30]. However, while an abundance of data
indicates that AMPK is activated across multiple cell types
during acute ischemic or toxic injury, the contribution by
AMPK to cell survival during and following acute injury
remains uncertain. Some studies have reported a cytopro-
tective role for AMPK [31-35], while others have found
that AMPK contributes to cell death [12,36-43]. The net
effect of AMPK on cell survival likely depends upon mul-
tiple variables, including cell lineage, the nature of the
Figure 8 Effect of knockdown of the α2 isoform on expression of the α1 and α2 isoforms and of total alpha domain in MPT cells from
α1−/− and WT mice. MPT cells from α1−/− mice, or their WT control, were infected with control (scrambled) shRNA or anti-α2 shRNA designed to
knock down the expression of the α2 isoform of AMPK. The relative expression of the α1 and α2 isoforms of AMPK, as well as of the total α
domain (α1 + α2), was evaluated in immunoblots of lysates from confluent MPT cells derived from the kidneys of α1−/− and α2−/− mice, and their
WT controls. Upper panel: Representative immunoblot. Molecular weight markers (in kDa) are shown om the right of each immunoblot. Lower
panel: Densitometric quantitation of three immunoblots using β-actin as a loading control. * p < 0.05, anti-α2 shRNA vs. control shRNA, for α2
isoform expression in MPT cells from WT and α1−/− mice; # p < 0.05, anti-α2 shRNA vs. control shRNA, for total alpha domain expression in MPT
cells from WT and α1−/− mice.
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toxic stimulus, and the specific pathways responsible for
AMPK activation. In the kidney, few data are available, re-
garding either the state of AMPK activity following ische-
mic injury, or the role of AMPK in modulating renal
tubular cell survival during metabolic stress.
Previously, we have shown that inhibition of AMPK,
either pharmacologically (using CC) or via knockdown
techniques, increased apoptosis of an immortalized
MPT cell line subjected to metabolic stress [18]. These
results suggested an anti-apoptotic role for AMPK in
metabolically stressed kidney cells. In this study, we
tested the hypothesis that primary cultures of MPT cells,
derived from AMPK KO mice lacking either the α1 or
α2 isoform of the catalytic domain, would be more sus-
ceptible to apoptosis induced by metabolic stress than
primary MPT cell cultures from their WT controls. To
our surprise, stress-induced death was no more severe in
MPT cells from KO mice compared MPT cells from the
WT controls (Figure 1). Moreover, while treatment of
MPT cells with antimycin in the presence of decreasing
concentrations of dextrose led to a progressive fall in cell
ATP levels (Figure 2), the decrease in cell ATP levels at
every degree of metabolic stress was comparable in KO
versus WT mice (Figure 2).
Our data suggest that the lack of difference in suscep-
tibility to stress-induced death by MPT cells from
AMPK KO versus WT mice is related to a compensatory
increase in the expression of the non-deleted alpha iso-
form that occurs in the kidney cortex (Figure 3) and
MPT cell cultures (Figure 4) from α1−/− and α2−/− mice.
Thus, expression of the α2 isoform of AMPK is up-
regulated in the cortex (Figure 3) and primary MPT cell
cultures (Figure 4) from the kidneys of α1−/− mice. Simi-
larly, expression of the α1 isoform is up-regulated in the
cortex (Figure 3) and primary MPT cell cultures (Figure 4)
from the kidneys of α2−/− mice. As a result, total α-
Figure 9 Effect of knockdown of the α2 isoform of AMPK on the activity of the AMPK pathway in MPT cells from α1−/− and WT mice.
MPT cells from α1−/− mice, or their WT control, were infected with control shRNA or anti-α2 shRNA designed to knock down the expression of
the α2 isoform of AMPK. MPT cells were subjected to metabolic stress by incubation in medium containing dextrose (5 mM) plus antimycin
(2 μM) for 4 hrs. Control cells were incubated in dextrose in the absence of antimycin. Activation of the AMPK pathway was assessed by
immunoblotting using antibodies that recognize either the phosphorylated (activated) form of AMPK or the phosphorylated (inhibited) form of
ACC. Expression of total AMPK was also assessed. Upper panel: Representative immunoblot. Molecular weight markers (in kDa) are shown om the
right of each immunoblot. Lower panel: Densitometric quantitation of three immunoblots using β-actin as a loading control. * p < 0.01, anti-α2
shRNA vs. control shRNA, for total α domain expression in MPT cells from WT or α1−/− mice; # p < 0.02, anti-α2 shRNA vs. control shRNA, for
phospho-AMPK expression in MPT cells from WT or α1−/− mice; p < 0.02, anti-α2 shRNA vs. control shRNA, for phospho-ACC expression in MPT
cells from WT or α1−/− mice.
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domain expression (α1 + α 2 isoforms) is comparable in
AMPK KO versus WT mice.
We next examined the effect of metabolic stress on
the phosphorylation, not only of the α-domain of
AMPK, but also of ACC, an immediate downstream tar-
get of AMPK that has been widely used as a marker of
AMPK activity [1]. Interestingly, metabolic stress in-
duced comparable degrees of phosphorylation of AMPK
and ACC in MPT cells from α1−/− mice, α2−/− mice and
both of their WT controls (Figure 5). These findings sug-
gest that equivalent expression of the total α-domain by
KO and WT mice is matched by functional equivalence
of AMPK activity.
We suggest that the lack of a difference in susceptibil-
ity to antimycin-induced cell death by MPT cells derived
from α1−/− and α2−/− mice versus their WT controls is
attributable to an adaptive equivalence in the amount
and activity of the total alpha isoform of AMPK in MPT
cells from the KO and WT mice. We further suggest
that that each α isoform can substitute for the other in
phosphorylation of downstream targets and in mediating
the anti-apoptotic functions of AMPK. This interpret-
ation is supported by studies in which we examined the
effects of inhibiting AMPK in primary cultures of MPT
cells from the AMPK KO and WT mice. Pharmaco-
logical inhibition of AMPK (using CC) of MPT cells
from AMPK KO and WT mice, reduced the antimycin-
induced phosphorylation of AMPK and ACC (Figure 6),
and exacerbated the stress-induced death of MPT cells
from the KO and WT mice (Figure 7). However, the
extent to which CC inhibited AMPK phosphorylation
(Figure 6), or worsened MPT cell death (Figure 7), was
not different between MPT cells derived from the KO
and WT mice. Similarly, inhibiting AMPK in MPT cells
obtained from α1−/− mice and their WT controls by
knocking down the α2 isoform using shRNA, decreased
antimycin-induced phosphorylation of AMPK and ACC
(Figure 9), and exacerbated the amount of death of MPT
cells (Figure 10) obtained from both the KO and WT
mice to a comparable degree.
Our data show that while genetic deletion of either the
α1 or α2 isoform of AMPK does not affect the response
of MPT cells to metabolic stress, inhibition of AMPK in-
duced by CC or molecular knockdown markedly in-
creases the susceptibility of MPT cells from WT and KO
mice to metabolic stress. It is likely that the compensa-
tory increase in expression of the non-deleted α-isoform
occurring in AMPK KO mice is due to increased protein
synthesis. We speculate that, in the case of acute inhib-
ition of AMPK, either by CC or molecular knockdown,
there is insufficient time for a compensatory increase of
protein synthesis of alpha isoforms to occur.
It is important to note that our results do not exclude
the possibility that the various isoforms of AMPK may
differ in role and function in different tissues [1,30]. To
date, very little data exist on the consequences of genetic
Figure 10 Effect of knockdown the α2 isoform of AMPK on the viability of MPT cells from α1−/− KO and WT mice subjected to
metabolic stress. A: MPT cells from α1−/− mice, or their WT control, were infected with control shRNA (solid lines) or anti-α2 shRNA designed to
knock down the expression of the α2 isoform of AMPK (dashed lines). Cells were then subjected to graded ATP depletion by incubation for
16–18 hrs in the presence of antimycin (2 μM) and varying concentrations of dextrose. The percentage of viable cells remaining was determined
by flow cytometry (n = 5). * p < 0.01, anti-α2 shRNA vs. control shRNA, for MPT cells from α1−/− or WT mice (ANOVA for repeated measures).
B: Representative flow cytometric analysis of metabolically stressed MPT cells from α2−/− mice infected with anti-α2 shRNA (right panels) or
control shRNA (left panels). Cell viability was quantified by staining cells with calcein AM (x-axis) and ethidium homodimer-1 (Eth-H1) (y-axis). For
each condition, 10,000 cells were analyzed, and the percentage of viable cells was calculated by dividing the number of calcein-positive and
Eth-H1-negative cells by the total number of cells counted.
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deletion of one isoform on the expression and activity of
the other isoform(s). Our results indicate that any at-
tempt to link a particular phenotype (or lack of pheno-
type) with the absence of one or other of the isoforms of
AMPK should be done with caution, since expression
and activity of the remaining isoform may be subject to
an adaptive up-regulation.
Conclusions
Our study has several major conclusions. First, primary
cultures of mouse proximal tubular (MPT) cells from
both α1−/− and α2−/− mice demonstrate an adaptive in-
crease in expression of the intact α-domain isoform of
AMPK, such that total α-domain expression is compar-
able in KO versus WT mice. Second, the α1 and α2 iso-
forms of AMPK are equally sensitive to metabolic stress,
since exposure to antimycin led to comparable increases
of AMPK activity in primary MPT cells from α1−/− and
α2−/− mice. Third, the α1 and α2 isoforms of AMPK
provide equivalent protection from stress-induced cell
death, since primary MPT cells from α1−/− and α2−/−
mice versus their WT controls were equally susceptible
to cell death from ATP depletion. Moreover, the use of
compound C to inhibit the activity of the α1 or the
α2 isoform in primary MPT cells derived from α2−/− and
α1−/− mice respectively, or the inhibition of the α2 iso-
form in primary MPT cells from α1−/− mice (via molecu-
lar knockdown) both exacerbated loss of cell viability in
response to ATP depletion to the same degree. Taken to-
gether, these data suggest that the α1- and α2-isoforms
of AMPK are not only similarly activated by ATP deple-
tion, but also similarly effective in reducing cell death
during metabolic stress. The adaptive up-regulation of
the intact isoform of AMPK in KO mice is consistent
with an overall critical role for AMPK in ameliorating
apoptosis of proximal tubular cells in response to acute
reductions of cellular ATP during ischemia.
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